Skip to main content
Publish date:

Jazz Pharma: FDA Panel Live Blog

Here's our live coverage of the FDA review of Jazz's fibromyalgia drug JZP-6.

PALO ALTO, Calif. (


) --

Jazz Pharmaceuticals

(JAZZ) - Get Jazz Pharmaceuticals Plc Report

brings its drug JZP-6 in front of an advisory committee of the U.S. Food and Drug Administration today, seeking a positive recommendation as a treatment for fibromyalgia.

Follow all the action from today's FDA advisory panel on our live blog.

TheStreet Recommends

-- Reported by Adam Feuerstein in Boston.

Follow Adam Feuerstein on



Adam Feuerstein writes regularly for In keeping with TSC's editorial policy, he doesn't own or short individual stocks, although he owns stock in He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback;

click here

to send him an email.